Epstein-Barr Virus-Positive Lymphomas Exploit Ectonucleotidase Activity To Limit Immune Responses and Prevent Cell Death
ABSTRACT Epstein-Barr virus (EBV) is a cancer-associated virus that infects more than 90% of adults. Unfortunately, many EBV-driven malignancies, including numerous B cell lymphomas, are highly aggressive and lack acceptable therapeutic outcomes. The concentrations of extracellular purines, namely,...
Main Authors: | Philip T. Lange, Blossom Damania |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2023-04-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.03459-22 |
Similar Items
-
How Epstein Barr Virus Causes Lymphomas
by: Ya-Fang Chiu, et al.
Published: (2024-11-01) -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
by: Alana Kennedy-Nasser, et al.
Published: (2009-11-01) -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
by: Helen Heslop, et al.
Published: (2009-11-01) -
Epstein-Barr virus: the mastermind of immune chaos
by: Jean de Melo Silva, et al.
Published: (2024-02-01) -
Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival
by: D. G. Sausen, et al.
Published: (2023-12-01)